面向一个全在一体的复合腺相关病毒载体,以使用CRISPR-Cas技术功能性地切除基因
Claire Verkuyl1,2, Ari Belotserkovsky1,2, Thomas Zerbes1,2
1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
PloS one
|November 7, 2025
概括
研究人员开发了一种新的基因编辑工具,使用腺相关病毒 (AAV) 载体来准和降低子蛋白 (PrPC) 水平,这是子疾病的关键因素. 这种方法对未来的性病疗法充满希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 子疾病需要降低大脑子蛋白 (PrPC) 水平的策略,以改善生存.
- 病毒介导基因治疗的进步使新的治疗方法的探索成为可能.
研究的目的:
- 开发一种用于CRISPR-Cas基因编辑的重组腺相关病毒 (rAAV) 载体,以实现基因的功能淘汰.
- 评估用于验证概念的子基因编辑研究的工具和方法.
主要方法:
- 在NCAM1促销器下构建了一个全在一体的rAAV载体,编码一个子基因特异性导向RNA和Cas9内核酶.
- 开发了第二个rAAV向量与交通信号记者 (TLR) 监测基因编辑效率.
- 在人类细胞和小鼠中进行了概念验证的基因编辑,并通过不同的注射途径比较了rAAV载体的大脑分布.
主要成果:
- 在人类细胞中达到大约20%的基因编辑率,在小鼠中达到5%.
- 确定9P31囊体在脑向量分布方面优越,表现出比PHP.eB的7.5倍更高的表达.
- 证明了RAAV介导的子基因编辑的概念验证.
结论:
- 一个用于子基因编辑的第一代rAAV矢量系统已经成功开发出来.
- 这项研究为优化子感染小鼠治疗评估的载体提供了基础.
- 9P31囊体是未来针对大脑的基于rAAV的基因治疗的有希望的候选者.
更多相关视频
11:28Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
Published on: May 23, 2016
18.2K
03:58Generation of Brown Fat-Specific Knockout Mice Using a Combined Cre-LoxP, CRISPR-Cas9, and Adeno-Associated Virus Single-Guide RNA System
Published on: March 24, 2023
3.1K
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
